Ameriprise Financial »

Summit Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 54k 20.66
2025-06-30 $699k 33k 21.28
2025-03-31 $817k 42k 19.29
2024-12-31 $406k 23k 17.85